SIRT1 silencing ameliorates malignancy of non-small cell lung cancer via activating FOXO1 DOI Creative Commons
Jiawei Chen,

Kebin Chen,

Shuai Zhang

и другие.

Scientific Reports, Год журнала: 2024, Номер 14(1)

Опубликована: Авг. 28, 2024

Non-small cell lung cancer (NSCLC), being the most prevalent and lethal malignancy affecting lungs, poses a significant threat to human health. This research aims at illustrating precise role related mechanisms of silent information regulator type-1 (SIRT1) in NSCLC progression. The expression pattern SIRT1 lines was examined using quantitative real-time polymerase chain reaction western blotting. Functional assays validated biological capabilities on malignant phenotypes, its impact tumorigenicity further evaluated vivo. In addition, FOXO1 inhibitor AS1842856 applied verify FOXO pathway vitro. prominently elevated lines. depletion retarded proliferation, migration invasion, while enhancing apoptosis cells. Furthermore, silencing restricted tumorigenesis Additionally, treatment ameliorated inhibitory effect deficiency phenotypes deletion exerted an anti-oncogenic via activation FOXO1.

Язык: Английский

Antioxidant Systems as Modulators of Ferroptosis: Focus on Transcription Factors DOI Creative Commons

Carolina Punziano,

Silvia Trombetti, Elena Cesaro

и другие.

Antioxidants, Год журнала: 2024, Номер 13(3), С. 298 - 298

Опубликована: Фев. 28, 2024

Ferroptosis is a type of programmed cell death that differs from apoptosis, autophagy, and necrosis related to several physio-pathological processes, including tumorigenesis, neurodegeneration, senescence, blood diseases, kidney disorders, ischemia–reperfusion injuries. linked iron accumulation, eliciting dysfunction antioxidant systems, which favor the production lipid peroxides, membrane damage, ultimately, death. Thus, signaling pathways evoking ferroptosis are strongly associated with those protecting cells against excess and/or lipid-derived ROS. Here, we discuss interaction between metabolic particular focus on transcription factors implicated in regulation ferroptosis, either as triggers peroxidation or defense pathways.

Язык: Английский

Процитировано

15

Disulfidptosis: A new type of cell death DOI Creative Commons
Fei Xiao, Huili Li, Bei Yang

и другие.

APOPTOSIS, Год журнала: 2024, Номер unknown

Опубликована: Июнь 17, 2024

Abstract Disulfidptosis is a novel form of cell death that distinguishable from established programmed pathways such as apoptosis, pyroptosis, autophagy, ferroptosis, and oxeiptosis. This process characterized by the rapid depletion nicotinamide adenine dinucleotide phosphate (NADPH) in cells high expression solute carrier family 7 member 11 (SLC7A11) during glucose starvation, resulting abnormal cystine accumulation, which subsequently induces andabnormal disulfide bond formation actin cytoskeleton proteins, culminating network collapse disulfidptosis. review aimed to summarize underlying mechanisms, influencing factors, comparisons with traditional pathways, associations related diseases, application prospects, future research directions

Язык: Английский

Процитировано

9

Targeting sirtuins for cancer therapy: epigenetics modifications and beyond DOI Creative Commons
Hui Shen,

Xinyi Qi,

Yue Hu

и другие.

Theranostics, Год журнала: 2024, Номер 14(17), С. 6726 - 6767

Опубликована: Янв. 1, 2024

Sirtuins (SIRTs) are well-known as nicotinic adenine dinucleotide

Язык: Английский

Процитировано

7

Intracellular C5aR1 inhibits ferroptosis in glioblastoma through METTL3-dependent m6A methylation of GPX4 DOI Creative Commons
Xiangrui Meng, Zixuan Wang, Qingqing Yang

и другие.

Cell Death and Disease, Год журнала: 2024, Номер 15(10)

Опубликована: Окт. 5, 2024

Язык: Английский

Процитировано

5

Single-cell sequencing elucidates the mechanism of NUSAP1 in glioma and its diagnostic and prognostic significance DOI Creative Commons

Meng-Yu Zhao,

Zhao-Wen Shen,

H Dai

и другие.

Frontiers in Immunology, Год журнала: 2025, Номер 16

Опубликована: Фев. 5, 2025

Background Personalized precision medicine (PPPM) in cancer immunology and oncology is a rapidly advancing field with significant potential. Gliomas, known for their poor prognosis, rank among the most lethal brain tumors. Despite advancements, there remains critical need precise, individualized treatment strategies. Methods We conducted comprehensive analysis of RNA-seq microarray data from TCGA GEO databases, supplemented by single-cell RNA sequencing (scRNA-seq) glioma patients. By integrating foundational experiments, we investigated molecular variations cellular interactions within neural cell subpopulations during tumor progression. Results Our revealed distinct gene expression patterns across subpopulations. Notably, differentiation trajectory identified NUSAP1 as key marker terminal subpopulation. found that elevated correlated prompting further investigation its functional role through both animal studies. Conclusions NUSAP1-based risk models hold potential predictive therapeutic tools personalized treatment. In-depth exploration NUSAP1’s mechanisms glioblastoma could enhance our understanding response to immunotherapy, suggesting targeting may offer benefits

Язык: Английский

Процитировано

0

Potential role of SIRT1 in cell ferroptosis DOI Creative Commons
Yueming Zhang,

Fanxiao Kong,

Nan Li

и другие.

Frontiers in Cell and Developmental Biology, Год журнала: 2025, Номер 13

Опубликована: Март 5, 2025

Ferroptosis is a novel form of cell death that uniquely requires iron and characterized by accumulation, the generation free radicals leading to oxidative stress, formation lipid peroxides, which distinguish it from other forms death. The regulation ferroptosis extremely complex closely associated with spectrum diseases. Sirtuin 1 (SIRT1), NAD + -dependent histone deacetylase, has emerged as pivotal epigenetic regulator potential regulate through wide array genes intricately metabolism, homeostasis, glutathione biosynthesis, redox homeostasis. This review provides comprehensive overview specific mechanisms SIRT1 regulates explores its therapeutic value in context multiple disease pathologies, highlighting significance SIRT1-mediated treatment strategies.

Язык: Английский

Процитировано

0

Tectorigenin mitigates homocysteine-induced inflammation and ferroptosis in BV-2 microglial cells through promoting the SIRT1/SLC7A11 pathway DOI Creative Commons

Yin Ye,

Bo Wang, Yan Yang

и другие.

Brain Research Bulletin, Год журнала: 2025, Номер unknown, С. 111272 - 111272

Опубликована: Март 1, 2025

Ferroptosis and inflammation are central to the pathophysiology of hyperhomocysteinemia (HHcy)-associated neurological disorders. Tectorigenin, a natural flavonoid aglycone extracted from numerous plants, possesses antioxidant, anti-inflammatory, neuroprotective properties. This study aimed investigate whether tectorigenin mitigates elevated homocysteine (Hcy)-induced toxicity in BV-2 microglial cells, focusing on its effects ferroptosis. Cell viability, lactate dehydrogenase (LDH) release, proliferation assays were employed evaluate cell injury. Inflammatory cytokines levels determined by ELISA. markers, including reactive oxygen species (ROS), lipid ROS, malondialdehyde (MDA), 4-hydroxy-nonenal (4-HNE), mitochondrial membrane potential (MMP), ATP, Fe2+ content, antioxidant enzymes (superoxide dismutase [SOD] catalase [CAT]) activities evaluated. mRNA protein expressions analyzed qRT-PCR western blotting, respectively. Our findings revealed that pretreatment significantly alleviated Hcy-induced injury inflammatory response cells. Furthermore, reduced peroxidation, enhanced capacity, ferroptotic death Hcy-treated Importantly, ferroptosis inhibitor Fer-1 also inflammation. Mechanistically, activated SIRT1/SLC7A11 pathway, silencing SIRT1 reversed protective effects. Collectively, these results indicate attenuates inhibiting through activation pathway.

Язык: Английский

Процитировано

0

A bibliometric and visual analysis of the impact of senescence on tumor immunotherapy DOI Creative Commons
Zixu Liu,

Y. J. Mao,

Shukai Wang

и другие.

Frontiers in Immunology, Год журнала: 2025, Номер 16

Опубликована: Апрель 11, 2025

Background Recently, many studies have focused on the relationship between senescence and immunotherapy in cancer treatment. However, relatively few examined intrinsic links three. Whether these can act synergistically fight against specific them are still unclear. Methods We extracted, quantified, visualized data from literature (n = 2396) for period 2004-2023 after rigorous quality control using citespace, GraphPad Prism, R software package, VOSviewer. Results Linear fit analyses were generated to predict number of annual publications citations as a function top-performing authors, journals, countries, affiliations academically over past two decades such Weiwei, Aging-us, China, UT MD Anderson Cancer Center. Vosviewer-based hierarchical clustering further categorized study characteristics into six clusters, including major clusters research, immunosenescence-related research factors, timeline distributions suggesting that cellular tumor progression is new cluster warrants exploration development. Study characterization bursts linear regression confirmed findings revealed other important results, aging (a 1.964, R² 0.6803) 16.38, 0.8812). Furthermore, gene frequency analysis this most abundant gene, APOE , SIRT1-7 proteins. Conclusion The combination therapies with immunotherapies currently its preliminary stages. Although has greatest impact ICB therapies, mechanistic investigations, drug development sirt1-7 (Sirtuins family) targets may be key combining treatment tumors.

Язык: Английский

Процитировано

0

Melatonin inhibits ferroptosis through the ATF3/GPX4 signaling pathway to relieve myocardial ischemia–reperfusion injury in rats DOI

Minjie He,

Yongheng Yang,

Xing He

и другие.

In Vitro Cellular & Developmental Biology - Animal, Год журнала: 2025, Номер unknown

Опубликована: Янв. 21, 2025

Язык: Английский

Процитировано

0

The landscape of ATF3 in tumors: metabolism, expression regulation, therapy approach, and open concerns DOI Creative Commons

Xu Zhao,

Chao Chen,

Hui Qiu

и другие.

Pharmacological Research, Год журнала: 2025, Номер unknown, С. 107666 - 107666

Опубликована: Фев. 1, 2025

Язык: Английский

Процитировано

0